Pavel Chernyavskiy

Dr. Pavel Chernyavskiy

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2017 in Statistics in Medicine
Verified
Journal Article
Closed access
PDF file
PCPavel Chernyavskiy
Pavel Chernyavskiy
MLMark P. Little
Mark P. Little
PRPhilip S. Rosenberg
Philip S. Rosenberg

11 September 2021 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
BLBrittny C Davis Lynn
Brittny C Davis Lynn
PCPavel Chernyavskiy
Pavel Chernyavskiy
GGGretchen L. Gierach
Gretchen L. Gierach
PRPhilip S Rosenberg
Philip S Rosenberg
Background: Incidence of estrogen receptor (ER)-negative breast cancer, an aggressive subtype, is highest in US African American women and in Southern residents but has decreased overall since 1992. We assessed whether ER-negative breast cancer is decreasing in all age groups and cancer registries among non-Hispanic White (NHW), non-Hispanic Black (NHB), and Hispanic White (HW) women. Methods: We analyzed 17 Surveillance, Epidemiology, and End-Results (SEER) Program registries (12 for 1992-2016; 5 for 2000-2016) to assess NHW, NHB, and HW trends by ER status and age group (30-39 years, 40-49 years, 50-69 years, 70-84 years). We used hierarchical age-period-cohort models that account for sparse data, which improve estimates to quantify between-registry heterogeneity in mean incidence rates and age-adjusted trends vs SEER overall. Results: Overall, ER-negative incidence was highest in NHB, then NHW and HW women, and decreased from 1992-2016 in each age group and racial or ethnic group. The greatest decrease was for HW women aged 40-49 years, with an annual percent change of –3.5%/y (95% credible interval = −4.4%, −2.7%) averaged over registries. The trend heterogeneity was statistically significant in every race or ethnic and age group. Furthermore, the incidence relative risks by race or ethnicity compared with the race-specific SEER average were also statistically significantly heterogeneous across the majority of registries and age groups (62 of 68 strata). The greatest heterogeneity was seen in HW women, followed by NHB women, and the least in NHW women. Conclusions: Decreasing ER-negative breast cancer incidence differs meaningfully by US region and age among NHB and HW women. Analytical studies including minority women from higher and lower incidence areas may provide insights into breast cancer racial disparities.

6 February 2020 in JNCI Cancer Spectrum
Verified
Journal Article
Open access
ATAlyssa W Tuan
Alyssa W Tuan
BLBrittny C Davis Lynn
Brittny C Davis Lynn
PCPavel Chernyavskiy
Pavel Chernyavskiy
MYMandi Yu
Mandi Yu
SGScarlett L Gomez
Scarlett L Gomez
PRPhilip S Rosenberg
Philip S Rosenberg
Background: Westernization and etiologic heterogeneity may play a role in the rising breast cancer incidence in Asian American (AA) women. We report breast cancer incidence in Asian-origin populations.Methods: Using a specialized Surveillance, Epidemiology, and End Results-9 Plus API Database (1990–2014), we analyzed breast cancer incidence overall, by estrogen receptor (ER) status, and age group among non-Hispanic white (NHW) and AA women. We used age-period-cohort models to assess time trends and quantify heterogeneity by ER status, race and ethnicity, and age.Results: Overall, breast cancer incidence increased for most AA ethnicities (Filipina: estimated annual percentage change [EAPC] = 0.96%/year, 95% confidence interval [CI] = 0.61% to 1.32%; South Asian: EAPC = 1.68%/year, 95% CI = 0.24% to 3.13%; Chinese: EAPC = 0.65%/year, 95% CI = 0.03% to 1.27%; Korean: EAPC = 2.55%/year, 95% CI = 0.13% to 5.02%; and Vietnamese women: EAPC = 0.88%/year, 95% CI = 0.37% to 1.38%); rates did not change for NHW (EAPC = -0.2%/year, 95% CI = -0.73% to 0.33%) or Japanese women (EAPC = 0.22%/year, 95% CI = -1.26% to 1.72%). For most AA ethnicities, ER-positive rates statistically significantly increased, whereas ER-negative rates statistically significantly decreased. Among older women, ER-positive rates were stable for NHW and Japanese women. ER-negative rates decreased fastest in NHW and Japanese women among both age groups.Conclusions: Increasing ER-positive incidence is driving an increase overall for most AA women despite declining ER-negative incidence. The similar trends in NHW and Japanese women (vs other AA ethnic groups) highlight the need to better understand the influences of westernization and other etiologic factors on breast cancer incidence patterns in AA women. Heterogeneous trends among AA ethnicities underscore the importance of disaggregating AA data and studying how breast cancer differentially affects the growing populations of diverse AA ethnic groups.

1 October 2021 in Journal of Educational Psychology
Verified
Journal Article
Closed access
DCDouglas Harvey Clements
Douglas Harvey Clements
JSJulie Sarama
Julie Sarama
ABArthur James Baroody
Arthur James Baroody
TKTraci S. Kutaka
Traci S. Kutaka
PCPavel Chernyavskiy
Pavel Chernyavskiy
EJEllen Joseph
Ellen Joseph

7 June 2017 in Statistical Methods in Medical Research
Verified
Journal Article
Closed access
PCPavel Chernyavskiy
Pavel Chernyavskiy
MLMark P Little
Mark P Little
PRPhilip S Rosenberg
Philip S Rosenberg
Age–period–cohort models are a popular tool for studying population-level rates; for example, trends in cancer incidence and mortality. Age–period–cohort models decompose observed trends into age effects that correlate with natural history, period effects that reveal factors impacting all ages simultaneously (e.g. innovations in screening), and birth cohort effects that reflect differential risk exposures that vary across birth years. Methodology for the analysis of multiple population strata (e.g. ethnicity, cancer registry) within the age–period–cohort framework has not been thoroughly investigated. Here, we outline a general model for characterizing differences in age–period–cohort model parameters for a potentially large number of strata. Our model incorporates stratum-specific random effects for the intercept, the longitudinal age trend, and the model-based estimate of annual percent change (net drift), thereby enabling a comprehensive analysis of heterogeneity. We also extend the standard model to include quadratic terms for age, period, and cohort, along with the corresponding random effects, which quantify possible stratum-specific departures from global curvature. We illustrate the utility of our model with an application to metastatic prostate cancer incidence (2004–2013) in non-Hispanic white and black men, using 17 population-based cancer registries in the Surveillance, Epidemiology, and End Results Program.

14 January 2019 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
PCPavel Chernyavskiy
Pavel Chernyavskiy
VKVictoria M. Kennerley
Victoria M. Kennerley
AJAhmedin Jemal
Ahmedin Jemal
MLMark P. Little
Mark P. Little
PRPhilip S. Rosenberg
Philip S. Rosenberg